Lattice Biologics Stock Market Value

LBLTF Stock  USD 0.0001  0.00  0.00%   
Lattice Biologics' market value is the price at which a share of Lattice Biologics trades on a public exchange. It measures the collective expectations of Lattice Biologics investors about its performance. Lattice Biologics is trading at 1.0E-4 as of the 27th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of Lattice Biologics and determine expected loss or profit from investing in Lattice Biologics over a given investment horizon. Check out Lattice Biologics Correlation, Lattice Biologics Volatility and Lattice Biologics Alpha and Beta module to complement your research on Lattice Biologics.
Symbol

Please note, there is a significant difference between Lattice Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lattice Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lattice Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Lattice Biologics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lattice Biologics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lattice Biologics.
0.00
10/28/2025
No Change 0.00  0.0 
In 2 months and 2 days
12/27/2025
0.00
If you would invest  0.00  in Lattice Biologics on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Lattice Biologics or generate 0.0% return on investment in Lattice Biologics over 60 days. Lattice Biologics is related to or competes with Verano Holdings, CellaVision, 4DMedical, PolyNovo, Euroapi SA, Beijing Tong, and Xvivo Perfusion. Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of... More

Lattice Biologics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lattice Biologics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lattice Biologics upside and downside potential and time the market with a certain degree of confidence.

Lattice Biologics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Lattice Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lattice Biologics' standard deviation. In reality, there are many statistical measures that can use Lattice Biologics historical prices to predict the future Lattice Biologics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lattice Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

Lattice Biologics Backtested Returns

We have found three technical indicators for Lattice Biologics, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Lattice Biologics are completely uncorrelated.

Auto-correlation

    
  0.00  

No correlation between past and present

Lattice Biologics has no correlation between past and present. Overlapping area represents the amount of predictability between Lattice Biologics time series from 28th of October 2025 to 27th of November 2025 and 27th of November 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lattice Biologics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Lattice Biologics price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

Lattice Biologics lagged returns against current returns

Autocorrelation, which is Lattice Biologics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lattice Biologics' pink sheet expected returns. We can calculate the autocorrelation of Lattice Biologics returns to help us make a trade decision. For example, suppose you find that Lattice Biologics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Lattice Biologics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lattice Biologics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lattice Biologics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lattice Biologics pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Lattice Biologics Lagged Returns

When evaluating Lattice Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lattice Biologics pink sheet have on its future price. Lattice Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lattice Biologics autocorrelation shows the relationship between Lattice Biologics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Lattice Biologics.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Lattice Pink Sheet

Lattice Biologics financial ratios help investors to determine whether Lattice Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lattice with respect to the benefits of owning Lattice Biologics security.